Solutions for New COVID-19 Variant and Post-Vaccination Monitoring

With the increasing in the vaccinated population, many countries are undergoing the transitioninig from pandemic to endemic COVID-19. However, the rise of new variants of concern (VOC) has decelerated the transition process. Scientists and researchers are increasing their effort to test and evaluate the effectiveness of vaccines and treatments against new VOC. Neutralizing antibodies (NAbs) are a critical component of the humoral adaptive immune mechanisms against viral infections. Therefore, analyzing NAb responses is crucial to evaluate vaccine-induced immune protection. In this webinar, Dr. Chengxun Su will discuss the following topics:

• Challenges and research priorities related to the Omicron variant
• NAb as the biomarker for Correlate of Protection for COVID-19 vaccines
• NAb kinetics and longevity in infected & vaccinated individuals
• Detection of NAb against Variant of Concern
• Solutions for Omicron-related research and development
• A NAb-guided personalized COVID-19 vaccine booster shot regimen

Related Products & Services

Speaker-related Webinars

Solutions for New COVID-19 Variant and Post-Vaccination Monitoring

Solutions for New COVID-19 Variant and Post-Vaccination Monitoring

Learn More